Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

DSpace Repository

Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy

Author: Reustle, Anna; Di Marco, Moreno; Meyerhoff, Carotin; Nelde, Annika; Walz, Juliane S.; Winter, Stefan; Kandabarau, Siahei; Buettner, Florian; Haag, Mathias; Backert, Linus; Kowalewski, Daniel J.; Rausch, Steffen; Hennenlotter, Joerg; Stuehler, Viktoria; Scharpf, Marcus; Fend, Falko; Stenzl, Arnulf; Rammensee, Hans-Georg; Bedke, Jens; Steyanovic, Stefan; Schwab, Matthias; Schaeffeler, Elke
Tübinger Autor(en):
Reustle, Anna
Di Marco, Moreno
Meyerhoff, Carolin
Nelde, Annika
Walz, Juliane S.
Winter, Stefan
Kandabarau, Siarhei
Büttner, Florian A.
Haag, Mathias
Backert, Linus
Kowalewski, Daniel Johannes
Rausch, Steffen
Hennenlotter, Jörg
Stühler, Viktoria
Scharpf, Marcus
Fend, Falko
Stenzl, Arnulf
Rammensee, Hans-Georg
Bedke, Jens
Stevanović, Stefan
Schwab, Matthias
Schäffeler, Elke
Published in: Genome Medicine (2020), Bd. 12, Article 32
Verlagsangabe: Bmc
Language: English
Full text: http://dx.doi.org/10.1186/s13073-020-00731-8
ISSN: 1756-994X
DDC Classifikation: 570 - Life sciences; biology
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)